Study Title: A phase II study to evaluate the efficacy of liposomal irinotecan in combination with oxaliplatin, leucovorin, and 5-fluorouracil for patients with locally advanced pancreatic carcinoma: Big Ten Cancer Research Consortium BTCRC-GI15-067
 

• Participating institutions:
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center
  • Robert H. Lurie Comprehensive Cancer Center of Northwestern University
  • Penn State Cancer Institute
  • Rutgers Cancer Institute of New Jersey
• Learn more:
  • clinicaltrials.gov: NCT03861702
  • Big Ten CRC News Release

Study Contact: studies@hoosiercancer.org; (317) 921-2050.